<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04860206</url>
  </required_header>
  <id_info>
    <org_study_id>PC-ZRS-SBI</org_study_id>
    <nct_id>NCT04860206</nct_id>
  </id_info>
  <brief_title>Post COVID19 Functional and Cognitive Assessments</brief_title>
  <acronym>PostCovidZRS</acronym>
  <official_title>Vpliv COVID19 na Izgubo Funkcionalnih zmožnosti Pacientov po zaključenem bolnišničnem Zdravljenju The Effect of COVID19 on the Loss of Functional Capacity of Patients After Hospitalization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Science and Research Centre Koper</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital of Izola</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Trieste</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Science and Research Centre Koper</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the proposed study is to evaluate the impact of coronavirus&#xD;
      (2019-nCoV), hereafter COVID -19, on patients' loss of functional capacity after completion&#xD;
      of hospital treatment. Specifically, the research will focus on examining changes in&#xD;
      musculoskeletal, cardiovascular, and respiratory function, as well as motor control. In&#xD;
      addition, we aim to evaluate rehabilitation treatments after recovery from COVID -19 and&#xD;
      consider additional preventive measures based on previous experience.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The combination of such a severe respiratory disease as COVID -19 with motor inactivity could&#xD;
      have very serious consequences for a person's general health even after COVID -19 symptoms&#xD;
      have subsided. To date, the effects of COVID -19 on individual muscle status have not been&#xD;
      extensively studied. Therefore, the main objective of this study will be to evaluate the&#xD;
      muscle status of patients after COVID -19. In addition, we will be interested in longitudinal&#xD;
      monitoring of individuals' rehabilitation, where they will receive instructions based on&#xD;
      measured outcomes at hospital discharge. We will also be interested in considering additional&#xD;
      preventive measures for future patients based on previous experience of infected and&#xD;
      hospitalized COVID -19 patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 5, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Timed up and go test (TUG)</measure>
    <time_frame>Change in time on TUG between both assessment points (pre- to 2 months post-measurement)</time_frame>
    <description>Functional performance of the patients from sitting to standing, walking and turning</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse wave velocity (PWV)</measure>
    <time_frame>Change in PWV between both assessment points (pre- to 2 months post-measurement)</time_frame>
    <description>Measuring endothelium function in supine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spirometry</measure>
    <time_frame>Change in FVC (%) between both assessment points (pre- to 2 months post-measurement)</time_frame>
    <description>Measurement of lung function, specifically the forced vital capacity (FVC)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Walking velocity</measure>
    <time_frame>Change in gait velocity between both assessment points (pre- to 2 months post-measurement)</time_frame>
    <description>measurement of gait velocity on the 4m path.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trail making test B</measure>
    <time_frame>Change in time to solve the TMT B test between both assessment points (pre- to 2 months post-measurement)</time_frame>
    <description>Measurement of executive control using the TMT B test</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Covid19</condition>
  <condition>Respiratory Disease</condition>
  <condition>Walking, Difficulty</condition>
  <condition>Cognitive Decline</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All male and female patients who tested positive for COVID -19 and were discharged from&#xD;
        hospital care will be enrolled in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Completed hospital treatment after a positive COVID-19 test&#xD;
&#xD;
          -  Signed written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Still testing positive for COVID -19 at discharge.&#xD;
&#xD;
          -  Severe musculoskeletal injuries (e.g., disability).&#xD;
&#xD;
          -  Inability to follow instructions when performing the test.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Rado Pisot, PhD</last_name>
    <phone>+386 5 663 77 00</phone>
    <email>rado.pisot@zrs-kp.si</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mladen Gasparini, PhD, MD</last_name>
    <phone>+386 5 660 60 00</phone>
    <email>mladen.gasparini@sb-izola.si</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SB Izola</name>
      <address>
        <city>Izola</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rado Pisot, PhD</last_name>
      <email>rado.pisot@zrs-kp.si</email>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <reference>
    <citation>Ammar A, Chtourou H, Boukhris O, Trabelsi K, Masmoudi L, Brach M, Bouaziz B, Bentlage E, How D, Ahmed M, Mueller P, Mueller N, Hsouna H, Aloui A, Hammouda O, Paineiras-Domingos LL, Braakman-Jansen A, Wrede C, Bastoni S, Pernambuco CS, Mataruna L, Taheri M, Irandoust K, Khacharem A, Bragazzi NL, Strahler J, Washif JA, Andreeva A, Khoshnami SC, Samara E, Zisi V, Sankar P, Ahmed WN, Romdhani M, Delhey J, Bailey SJ, Bott NT, Gargouri F, Chaari L, Batatia H, Ali GM, Abdelkarim O, Jarraya M, Abed KE, Souissi N, Gemert-Pijnen LV, Riemann BL, Riemann L, Moalla W, Gómez-Raja J, Epstein M, Sanderman R, Schulz S, Jerg A, Al-Horani R, Mansi T, Jmail M, Barbosa F, Ferreira-Santos F, Šimunič B, Pišot R, Pišot S, Gaggioli A, Zmijewski P, Apfelbacher C, Steinacker J, Saad HB, Glenn JM, Chamari K, Driss T, Hoekelmann A, On Behalf Of The Eclb-Covid Consortium. COVID-19 Home Confinement Negatively Impacts Social Participation and Life Satisfaction: A Worldwide Multicenter Study. Int J Environ Res Public Health. 2020 Aug 27;17(17). pii: E6237. doi: 10.3390/ijerph17176237.</citation>
    <PMID>32867287</PMID>
  </reference>
  <reference>
    <citation>Ammar A, Brach M, Trabelsi K, Chtourou H, Boukhris O, Masmoudi L, Bouaziz B, Bentlage E, How D, Ahmed M, Müller P, Müller N, Aloui A, Hammouda O, Paineiras-Domingos LL, Braakman-Jansen A, Wrede C, Bastoni S, Pernambuco CS, Mataruna L, Taheri M, Irandoust K, Khacharem A, Bragazzi NL, Chamari K, Glenn JM, Bott NT, Gargouri F, Chaari L, Batatia H, Ali GM, Abdelkarim O, Jarraya M, Abed KE, Souissi N, Van Gemert-Pijnen L, Riemann BL, Riemann L, Moalla W, Gómez-Raja J, Epstein M, Sanderman R, Schulz SV, Jerg A, Al-Horani R, Mansi T, Jmail M, Barbosa F, Ferreira-Santos F, Šimunič B, Pišot R, Gaggioli A, Bailey SJ, Steinacker JM, Driss T, Hoekelmann A. Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey. Nutrients. 2020 May 28;12(6). pii: E1583. doi: 10.3390/nu12061583.</citation>
    <PMID>32481594</PMID>
  </reference>
  <reference>
    <citation>Pišot R, Marusic U, Biolo G, Mazzucco S, Lazzer S, Grassi B, Reggiani C, Toniolo L, di Prampero PE, Passaro A, Narici M, Mohammed S, Rittweger J, Gasparini M, Gabrijelčič Blenkuš M, Šimunič B. Greater loss in muscle mass and function but smaller metabolic alterations in older compared with younger men following 2 wk of bed rest and recovery. J Appl Physiol (1985). 2016 Apr 15;120(8):922-9. doi: 10.1152/japplphysiol.00858.2015. Epub 2016 Jan 28.</citation>
    <PMID>26823343</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 20, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID19</keyword>
  <keyword>functional outcomes</keyword>
  <keyword>respiratory function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Mobility Limitation</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

